| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a582345cc0db03f15580041212f85452 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-067 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-34 |
| filingDate |
2021-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70b327a3fc2b2f549c8d2d224aecc628
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fc262a1daf7dda2540daf1a50a9f733
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ee255c59188b4bd528f7ca2e615b04d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_464e84103ed1014905ea4e773b90fd54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe520a1c0c2699f197f2f61e682866bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72c5fc19b8bc1824e6fbbd8e4c5e42c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51046b77d840d363196189c136e56e76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c63ea6c06b4cafc03579f08fb2fa1149
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3b9c0f99d126d49c9aeebce0e3ff589 |
| publicationDate |
2021-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-113655144-A |
| titleOfInvention |
A predictive model for early warning of severe acute pancreatitis based on pyruvate kinase and α-2-HS-glycoprotein |
| abstract |
The invention discloses a prediction model for early warning severe acute pancreatitis based on pyruvate kinase and α-2-HS-glycoprotein, and belongs to the technical field of biological detection. The prediction model is pyruvate kinase and α2-HS-glycoprotein in serum. By detecting the changes in the content of pyruvate kinase and α2-HS-glycoprotein in serum, within 48 hours of the patient's illness, it can distinguish between moderate and severe acute pancreatitis and acute pancreatitis. Severe acute pancreatitis has good guiding significance. |
| priorityDate |
2021-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |